Pipeline Watch
13 November 2009
This week, Scrip’s Pipeline Watch records progress for GlaxoSmithKline with its vaccine portfolio, but a setback for its biopharmaceuticals pipeline. During its second-quarter financial results presentation, the UK firm confirmed a US filing for its new vaccine, MenHibrix (HibMenCY-TT), against...
Please Login to read the full article.
13 November 2009
This week, Scrip’s Pipeline Watch records progress for GlaxoSmithKline with its vaccine portfolio, but a setback for its biopharmaceuticals pipeline. During its second-quarter financial results presentation, the UK firm confirmed a US filing for its new vaccine, MenHibrix (HibMenCY-TT), against...
Please Login to read the full article.
RELATED CONTENT
NEWS
- GSK ploughs on despite second complete response letter for MenHibrix combi vaccine
- A year in pharma and biotech R&D: Healthy numbers belie lack of novelty
- Sanofi licenses novel monoclonal from Glenmark for up to $663 million
- CHMP positive opinions for AstraZeneca, Merck KGaA, Roche, Alcon and Merck-Serono
COMMENT
Other Informa Comment
EVENTS
09 February 2012
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
